| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Holly R. Yeatman | Q56112026 |
| Jessica K Holien | Q82218645 | ||
| Philip E. Thompson | Q38804514 | ||
| Michael W Parker | Q41147578 | ||
| P2093 | author name string | Anthony L Albiston | |
| Siew Yeen Chai | |||
| Broden Morgan | |||
| Ruani N Fernando | |||
| Shanti Diwakarla | |||
| Simon J Mountford | |||
| Vi Pham | |||
| P2860 | cites work | Oxytocin Makes a Face in Memory Familiar | Q22255500 |
| Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation | Q24290820 | ||
| Placental leucine aminopeptidase/oxytocinase in maternal serum and placenta during normal pregnancy | Q73518080 | ||
| Cyclic insulin-regulated aminopeptidase (IRAP)/AT4 receptor ligands | Q80246319 | ||
| Human placental leucine aminopeptidase/oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family | Q24315214 | ||
| Functional requirement for class I MHC in CNS development and plasticity | Q24669537 | ||
| Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease | Q24678457 | ||
| Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase | Q27653672 | ||
| IRAP identifies an endosomal compartment required for MHC class I cross-presentation | Q28114994 | ||
| Different cross-presentation pathways in steady-state and inflammatory dendritic cells | Q28115137 | ||
| Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides | Q28199101 | ||
| Regulated transport of the glucose transporter GLUT4 | Q28216848 | ||
| Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles | Q28569814 | ||
| Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats | Q28570454 | ||
| Involvement of D1 dopamine receptors in the cognitive effects of angiotensin IV and des-Phe6 angiotensin IV | Q28573288 | ||
| Spatial memory formation and memory-enhancing effect of glucose involves activation of the tuberous sclerosis complex-Mammalian target of rapamycin pathway | Q28575179 | ||
| Distribution and cellular localization of insulin-regulated aminopeptidase in the rat central nervous system | Q28579048 | ||
| The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro | Q28579223 | ||
| Mice deficient in the insulin-regulated membrane aminopeptidase show substantial decreases in glucose transporter GLUT4 levels but maintain normal glucose homeostasis | Q28589946 | ||
| Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task | Q30305450 | ||
| Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. | Q30444206 | ||
| Memory enhancement with posttraining intraventricular glucose injections in rats | Q30461805 | ||
| Intraseptal infusions of muscimol impair spontaneous alternation performance: infusions of glucose into the hippocampus, but not the medial septum, reverse the deficit | Q30470656 | ||
| Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections. | Q30471648 | ||
| Glucose, memory, and aging | Q30471944 | ||
| Therapeutic targeting of insulin-regulated aminopeptidase: heads and tails? | Q33300628 | ||
| Angiotensin IV and LVV-haemorphin 7 enhance spatial working memory in rats: effects on hippocampal glucose levels and blood flow | Q33411176 | ||
| The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor | Q33755200 | ||
| Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials | Q33912750 | ||
| Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1 | Q34023384 | ||
| Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation | Q34103606 | ||
| Structure of aminopeptidase N from Escherichia coli suggests a compartmentalized, gated active site | Q35037226 | ||
| De Wied and colleagues IV: research into mechanisms of action by which vasopressin and oxytocin influence memory processing | Q35879156 | ||
| Somatostatin signaling in neuronal cilia is critical for object recognition memory. | Q37347565 | ||
| Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias. | Q37388456 | ||
| Reproduction and maternal behavior in insulin-regulated aminopeptidase (IRAP) knockout mice. | Q37569132 | ||
| Participation of D 1-4 dopamine receptors in the pro-cognitive effects of angiotensin IV and des-Phe 6 angiotensin IV. | Q37581159 | ||
| Emerging cognitive enhancing drugs | Q37601479 | ||
| Immune proteins in brain development and synaptic plasticity. | Q37617631 | ||
| Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture. | Q38320374 | ||
| Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats. | Q38450522 | ||
| Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP). | Q39636315 | ||
| Phenylalanine-544 plays a key role in substrate and inhibitor binding by providing a hydrophobic packing point at the active site of insulin-regulated aminopeptidase | Q39680651 | ||
| Beta-homo-amino acid scan of angiotensin IV. | Q39995293 | ||
| Small potent ligands to the insulin-regulated aminopeptidase (IRAP)/AT(4) receptor. | Q40122056 | ||
| Sub-cellular localization of insulin-regulated membrane aminopeptidase, IRAP to vesicles in neurons | Q40132721 | ||
| Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. | Q40768845 | ||
| Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats. | Q42599380 | ||
| The amino terminus of insulin-responsive aminopeptidase causes Glut4 translocation in 3T3-L1 adipocytes | Q42795999 | ||
| Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes | Q42802101 | ||
| Intrahippocampal Norleucine¹-Angiotensin IV mitigates scopolamine-induced spatial working memory deficits | Q42917818 | ||
| The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues | Q43275899 | ||
| Gene knockout of insulin-regulated aminopeptidase: loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory | Q43297455 | ||
| Angiotensin IV enhances LTP in rat dentate gyrus in vivo | Q43713596 | ||
| A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits | Q43814000 | ||
| Ethanol-induced suppression of LTP can be attenuated with an angiotensin IV analog | Q44397760 | ||
| Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). | Q44518988 | ||
| Norleucine1-Angiotensin IV alleviates mecamylamine-induced spatial memory deficits | Q44828738 | ||
| Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms | Q45012094 | ||
| The circulating vasopressinase of pregnancy: Species comparison with radioimmunoassay | Q45905091 | ||
| The insulin-regulated aminopeptidase IRAP is colocalised with GLUT4 in the mouse hippocampus--potential role in modulation of glucose uptake in neurones? | Q46430078 | ||
| Regulation of class I MHC gene expression in the developing and mature CNS by neural activity | Q46490752 | ||
| Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. | Q46503099 | ||
| Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2. | Q46538139 | ||
| Effect of D(3) dopamine receptors blockade on the cognitive effects of angiotensin IV in rats. | Q46688100 | ||
| Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning | Q48218315 | ||
| Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory | Q48381985 | ||
| The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain | Q48701785 | ||
| The effect of angiotensin II and its fragments on post-alcohol impairment of learning and memory | Q48822233 | ||
| Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats | Q48934009 | ||
| Strain differences in the effects of angiotensin IV on mouse cognition. | Q51049778 | ||
| Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase. | Q51950733 | ||
| Glucose attenuation of memory impairments. | Q52026760 | ||
| Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats. | Q52048507 | ||
| Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. | Q52185174 | ||
| Functional evidence for an angiotensin IV receptor in rat resistance arteries. | Q54075062 | ||
| Analysis of responses to angiotensin IV in the pulmonary vascular bed of the cat. | Q54197564 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 37-47 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers | |
| P478 | volume | 164 |
| Q57351610 | A green synthesis of spirooxindole derivatives catalyzed by SiO2@g-C3N4 nanocomposite |
| Q52763817 | A mild removal of Fmoc group using sodium azide. |
| Q26779600 | Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications |
| Q38848234 | Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology |
| Q35894732 | Binding to and Inhibition of Insulin-Regulated Aminopeptidase by Macrocyclic Disulfides Enhances Spine Density |
| Q92000745 | Brain Vasculature and Cognition |
| Q42555106 | Crystal structure of human insulin-regulated aminopeptidase with specificity for cyclic peptides. |
| Q34543485 | Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers. |
| Q36685572 | Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders |
| Q46070919 | Identification of an oxytocinase/vasopressinase-like leucyl-cystinyl aminopeptidase (LNPEP) in teleost fish and evidence for hypothalamic mRNA expression linked to behavioral social status. |
| Q43086630 | Inhibition of Insulin-Regulated Aminopeptidase (IRAP) by Arylsulfonamides |
| Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
| Q86068125 | K2CO3-mediated synthesis of functionalised 4-substituted-2-amino-3-cyano-4H-chromenes via Michael-cyclization reactions |
| Q39079405 | M1 aminopeptidases as drug targets: broad applications or therapeutic niche? |
| Q38217456 | Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors |
| Q38781022 | Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy |
| Q34267391 | New directions in the treatment of autism spectrum disorders from animal model research |
| Q41971058 | Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice |
| Q54380711 | Patent Highlights October-November 2016. |
| Q42806618 | Presence and regulation of insulin-regulated aminopeptidase in mouse macrophages. |
| Q61785672 | Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Aryl Sulfonamides |
| Q38685683 | Supplementation with zinc in rats enhances memory and reverses an age-dependent increase in plasma copper |
| Q52347539 | The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment? |
| Q38005611 | The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases |
| Q36353312 | The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies |
| Q48141395 | Trans-Modulation of the Somatostatin Type 2A Receptor Trafficking by Insulin-Regulated Aminopeptidase Decreases Limbic Seizures. |
Search more.